High density lipoprotein-cholesterol levels increase with age in American women but not in Hong Kong Chinese women

Clinical Endocrinology

Volumn 70, Issue 4, 2009, Pages 561-568

  Cheung, Bernard M Y ^a   Li, Mingfang ^b   Ong, Kwok Leung ^b   Wat, Nelson M S ^b   Tam, Sidney ^c   Pang, Richard W C ^c   Thomas, G Neil ^a   Woo, Jean ^d   Janus, Edward D ^e   Lau, Chu Pak ^b   Lam, Tai Hing ^b   Lam, Karen S L ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c QUEEN MARY HOSPITAL   (Hong Kong)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SALVAGE; CARDIOVASCULAR RISK; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EXERCISE; FEMALE; HISPANIC; HONG KONG; HUMAN; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; AGING; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HONG KONG; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; RISK FACTORS; SEX CHARACTERISTICS; UNITED STATES;

EID: 61449186540     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03361.x     Document Type: Article

References (41)

1. Baigent, C., Keech Kearney, A., Blackwell, P.M. et al. (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet, 366, 1267 1278.
2. Cheung, B.M.Y., Lauder, I.J., Lau, C.P. et al. (2004) Meta-analysis of large randomised controlled trials to evaluate the impact of statins on cardiovascular outcomes. British Journal of Clinical Pharmacology, 57, 640 651.
3. Deedwania, P., Barter Carmena, P., Fruchart, R. et al. (2006) Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. Lancet, 368, 919 928.
4. Gordon, T., Castelli, W.P., Hjortland, M.C. et al. (1977) High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. American Journal of Medicine, 62, 707 714.
5. Anderson, K.M., Odell, P.M., Wilson, P.W. et al. (1991) Cardiovascular disease risk profiles. American Heart Journal, 121, 293 298.
6. Kannel, W.B. (1995) Range of serum cholesterol values in the population developing coronary artery disease. American Journal of Cardiology, 76, 69C 77C.
7. Hansel, B., Kontush, A., Giral, P. et al. (2006) One third of the variability in HDL-cholesterol level in a large dyslipidaemic population is predicted by age, sex and triglyceridaemia: The Paris La Pitie Study. Current Medical Research Opinions, 22, 1149 1160.
8. Klos, K.L. Kullo, I.J. (2007) Genetic determinants of HDL: monogenic disorders and contributions to variation. Current Opinions in Cardiology, 22, 344 351.
9. Schwingel, A., Nakata, Y., Ito, L.S. et al. (2007) Lower HDL-cholesterol among healthy middle-aged Japanese-Brazilians in Sao Paulo compared to Natives and Japanese-Brazilians in Japan. European Journal of Epidemiology, 22, 33 42.
10. Iwao, N., Iwao, S., Muller, D.C. et al. (2005) Differences in the relationship between lipid CHD risk factors and body composition in Caucasians and Japanese. International Journal of Obesity, 29, 228 235.
11. Carr, M.C., Brunzell, J.D. Deeb, S.S. (2004) Ethnic differences in hepatic lipase and HDL in Japanese, black, and white Americans: role of central obesity and LIPC polymorphism. Journal of Lipid Research, 45, 466 473.
12. Kim, S.M., Han, J.H. Park, H.S. (2006) Prevalence of low HDL-cholesterol levels and associated factors among Koreans. Circulation Journal, 70, 820 826.
13. Kesteloot, H., Lee, C.S., Park, H.M. et al. (1982) A comparative study of serum lipids between Belgium and Korea. Circulation, 65, 795 799.
14. Knuiman, J.T., West, C.E. Burema, J. (1982) Serum total and high density lipoprotein cholesterol concentrations and body mass index in adult men from 13 countries. American Journal of Epidemiology, 116, 631 642.
15. Simons, L.A. (1986) Interrelations of lipids and lipoproteins with coronary artery disease mortality in 19 countries. American Journal of Cardiology, 57, 5G 10G.
16. National Center for Health Statistics (2007) National Health and Nutrition Examination Survey. Available at: http://www.cdc.gov/nchs/nhanes.htm (Accessed August, 27).
17. Centers for Disease Control Prevention, 2007 (CDC 2007) National Health and Nutrition Examination Survey questionnaire, Examination Protocol and Laboratory Protocol. United States Department of Health and Human Services, Centers for Disease Control and Prevention 1999-2002, Hyattsville, Maryland. Available at: http://www.cdc.gov/nchs/data/nhanes (Accessed August, 27).
18. National Center for Health Statistics, 2007 (2007) National Health and Nutrition Examination Survey (NHANES) Analytic Guidelines. Available at : http://www.cdc.gov/nchs/about/major/nhanes/nhanes2003-2004/analytical- guidelines.htm (Accessed May 9, 2007).
19. Carroll, M.D., Lacher, D.A., Sorlie, P.D. et al. (2005) Trends in lipids and lipoproteins of adults, 1960-2002. Journal of the American Medical Association, 294, 1773 1781.
20. Kim, J.K., Alley, D., Seeman, T. et al. (2006) Recent changes in cardiovascular risk factors among women and men. Journal of Women's Health, 15, 734 746.
21. Lopez, V.A., Franklin, S.S., Tang, S. et al. (2007) Coronary heart disease events preventable by control of blood pressure and lipids in US adults with hypertension. Journal of Clinical Hypertension, 9, 436 443.
22. Hsia, S.H., Pan, D., Berookim, P. et al. (2006) A population-based, cross-sectional comparison of lipid-related indexes for symptoms of atherosclerotic disease. American Journal of Cardiology, 98, 1047 1052.
23. Tande, D.L., Hotchkiss, L. Cotugna, N. (2004) The associations between blood lipids and the food guide pyramid: findings from the third national health and nutrition examination survey. Preventive Medicine, 38, 452 457.
24. Lam, T.H., Liu, L.J., Janus, E.D. et al. (1999) The relationship between fibrinogen and other coronary heart disease risk factors in a Chinese population. Atherosclerosis, 143, 405 413.
25. Thomas, G.N., Schooling, M., McGhee, S.M. et al. (2006) Identification of factors differential associated with isolated impaired fasting glucose and isolated post-load impaired glucose tolerance: the Hong Kong Cardiovascular Risk Factor Study. European Journal of Endocrinology, 155, 1 11.
26. Pang, R.W., Tam, S., Janus, E.D. et al. (2006) Plasma lipid, lipoprotein and apolipoprotein levels in a random population sample of 2875 Hong Kong Chinese adults and their implications (NCEP ATP-III, 2001 guidelines) on cardiovascular risk assessment. Atherosclerosis, 184, 438 445.
27. Cheung, B.M.Y., Wat, N.M.W., Man, Y.B. et al. (2007) Development of diabetes in Chinese with the metabolic syndrome - a six year prospective study. Diabetes Care, 30, 1430 1436.
28. Thomas, G.N., Schooling, C.M., McGhee, S.M. et al. (2007) Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor Study. Clinical Endocrinology, 66, 666 671.
29. Cheung, B.M.Y., Wat, N.M.W., Man, Y.B. et al. (2008) Relationship between metabolic syndrome and the development of hypertension in the Hong Kong Cardiovascular Risk Factor Prevalence Study 2. American Journal of Hypertension, 21, 17 22.
30. Cheung, B.M.Y., Wat, N.M.W., Tam, S. et al. (2008) Components of the metabolic syndrome predictive of its development: a 6-year longitudinal study in Hong Kong Chinese. Clinical Endocrinology, 68, 730 737.
31. Katan, M.B., Zock, P.L. Mensink, R.P. (1994) Effects of fats and fatty acids on blood lipids in humans: an overview. American Journal of Clinical Nutrition, 60 (Suppl 1017S 1022S.
32. Davis, C.E., Pajak, A., Rywik, S. et al. (1994) Natural menopause and cardiovascular disease risk factors. The Poland and US Collaborative Study on Cardiovascular Disease Epidemiology. Annals of Epidemiology, 4, 445 448.
33. Demirovic, J., Sprafka, J.M., Folsom, A.R. et al. (1992) Menopause and serum cholesterol: differences between blacks and whites. The Minnesota Heart Survey. American Journal of Epidemiology, 136, 155 164.
34. Bonithon-Kopp, C., Scarabin, P.Y., Darne, B. et al. (1990) Menopause-related changes in lipoproteins and some other cardiovascular risk factors. International Journal of Epidemiology, 19, 42 48.
35. Peters, H.W., Westendorp, I.C., Hak, A.E. et al. (1999) Menopausal status and risk factors for cardiovascular disease. Journal of Internal Medicine, 246, 521 528.
36. Wu, Z.Y., Wu, X.K. Zhang, Y.W. (1990) Relationship of menopausal status and sex hormones to serum lipids and blood pressure. International Journal of Epidemiology, 19, 297 302.
37. Stevenson, J.C., Crook, D. Godsland, I.F. (1993) Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis, 98, 83 90.
38. Canner, P.L., Berge, K.G., Wenger, N.K. et al. (1986) Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. Journal of the American College of Cardiology, 8, 1245 1255.
39. Brown, B.G., Zhao, X.Q., Chait, A. et al. (2001) Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. The New England Journal of Medicine, 345, 1583 1592.
40. Taylor, A.J., Sullenberger, L.E., Lee, H.J. et al. (2004) Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation, 110, 3512 3517.
41. Nissen, S.E., Tsunoda, T., Tuzcu, E.M. et al. (2003) Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. Journal of the American Medical Association, 290, 2292 2300.